<SEC-DOCUMENT>0001040130-25-000077.txt : 20251021
<SEC-HEADER>0001040130-25-000077.hdr.sgml : 20251021
<ACCEPTANCE-DATETIME>20251021162221
ACCESSION NUMBER:		0001040130-25-000077
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20251019
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251021
DATE AS OF CHANGE:		20251021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42429
		FILM NUMBER:		251407332

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pets-20251019.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b25d766c-3bfe-409e-b6e6-a74676f70a32,g:e571ee22-3a85-4a9d-aa25-d2857ed5c299,d:fc6a2a7c0e21475291330a18192bb8ae-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pets-20251019</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0001040130</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pets-20251019.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-19</xbrli:startDate><xbrli:endDate>2025-10-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-19</xbrli:startDate><xbrli:endDate>2025-10-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-19</xbrli:startDate><xbrli:endDate>2025-10-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ifc6a2a7c0e21475291330a18192bb8ae_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">October 19, 2025</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">PetMed Express, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Florida</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-28827</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">65-0680967</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">420 South Congress Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Delray Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">33445</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">561</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">526-4444</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-17">Common Stock, par value $.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-18">PETS</ix:nonNumeric></span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" id="f-19">NASDAQ</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-20">Preferred Stock Purchase Rights</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="dei:NoTradingSymbolFlag" format="ixt:fixed-true" id="f-21">N/A</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" id="f-22">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the </span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:125%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><div id="ifc6a2a7c0e21475291330a18192bb8ae_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">(d) Appointment of Director</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On October 19, 2025, the Board of Directors (the &#8220;Board&#8221;) of PetMed Express, Inc. (the &#8220;Company&#8221;), appointed James LaCamp to serve as a director of the Company effective immediately.  Mr. LaCamp will hold this position until the 2025 annual meeting of the Company&#8217;s stockholders or until his successor is elected and qualified, subject to his earlier resignation or removal. Mr. LaCamp has been appointed to serve immediately on the Board&#8217;s Audit Committee and on the Compensation and Human Capital Committee, and will serve as Audit Committee Chair beginning October 30, 2025. Mr. LaCamp  qualifies as an &#8220;audit committee financial expert&#8221; within the meaning of the rules and regulations of the Securities and Exchange Commission.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Mr. LaCamp, age 42, currently serves as the Chief Financial Officer of Skydio, Inc. a position he has held since September 2024. Skydio is one of the nation&#8217;s leading autonomous drone providers, and Mr. LaCamp is responsible for all aspects of the company&#8217;s financial operations, including accounting, information technology, security, treasury, tax, and data &amp; analytics.  Prior to joining Skydio, from June 2022 until June 2024, Mr. LaCamp was the Chief Financial Officer of Flock Safety, a safety technology provider. Before Flock Safety, Mr. LaCamp held multiple finance leadership roles at Coupa Software, a business spend management provider, from December 2018 until June 2022, most recently serving as its Senior Vice President Finance. He also held multiple leadership roles at Deloitte &amp; Touche LLP from 2006 to 2018, most recently serving as a Partner and U.S. Technology Industry - Software Leader of Deloitte &amp; Touche LLP. Since November 2019, Mr. LaCamp served on the board of directors of Performant Healthcare Technologies (formerly NASDAQ: PHLT), a healthcare technology provider, and was chair of the audit committee and a member of the compensation and nominating and governance committees from November 2019 until the company&#8217;s acquisition by Machinify on October 21, 2025. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Mr. LaCamp holds a B.S.C. in Accounting from Santa Clara University and an M.B.A. from the Wharton School of Business at the University of Pennsylvania. He is also a licensed Certified Public Accountant in California and Washington.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Board believes that Mr. LaCamp&#8217;s background and expertise will contribute significantly to the Company&#8217;s financial governance and oversight. Mr. LaCamp has approximately 20 years of experience in finance, accounting, and audit, including serving in a senior leadership role at a large public accounting firm, where he was responsible for managing audits of a broad range of entities, including early-stage companies and Fortune 50 technology corporations. Additionally, Mr. LaCamp has held key financial executive positions, including Chief Financial Officer, at multiple technology companies, where he was responsible for financial management, strategic financial planning, and operational oversight.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There are no family relationships between Mr. LaCamp and any other executive officers or directors of the Company. There is no arrangement or understanding between Mr. LaCamp and any other persons pursuant to which he was selected as director. There are no transactions to which the Company is a party and in which Mr. LaCamp has a material interest that is required to be disclosed under Item 404(a) of Regulation S-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In connection with his appointment to the Board, Mr. LaCamp will receive compensation in accordance with the Company&#8217;s Non-Employee Director Compensation Program filed as Exhibit 10.9.12 to the Company&#8217;s Annual Report on Form 10-K for its fiscal year ended March 31, 2025, filed with the Securities and Exchange Commission on October 14, 2025 (the &#8220;2025 Form 10-K&#8221;). The Company also intends to enter into an indemnification agreement with Mr. LaCamp in the same form as the Company&#8217;s standard form indemnification agreement with its other directors, which is filed as Exhibit 10.2 to the Company&#8217;s 2025 Form 10-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">(e) Entry into Employment Agreement with Interim CEO and President</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On October 20 2025, the Board approved, and the Company entered into, an Interim Executive Employment Agreement with Leslie C.G. Campbell that will govern the terms of Ms. Campbell&#8217;s role as Interim Chief Executive Officer and President of the Company (the &#8220;Employment Agreement&#8221;).  The Employment Agreement provides that Ms. Campbell will serve as Interim Chief Executive Officer and President for a term of one year beginning on August 11, 2025 and continuing through August 10, 2026, provided that Ms. Campbell&#8217;s employment is on an at-will basis and may be terminated earlier at any time by either the Board or Ms. Campbell with or without cause and without any severance compensation payable to Ms. Campbell.  As provided in the Employment Agreement, Ms. Campbell will serve the Company on a full-time basis, will work in-person from the Company&#8217;s Delray Beach, Florida headquarters, and will receive an annual base salary of $1.3 million, which may be increased in the discretion of the Board (but may not be decreased other than as part of a proportionate reduction in management salaries and wages applicable to all senior management).  Ms. Campbell will be entitled to 4 weeks of vacation each year, will receive customary expense reimbursement (in accordance with the Company&#8217;s standard policies), and will receive the medical, health, and other benefits provided to Company employees </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">generally, including participation in the Company&#8217;s 401(k) plan on the same basis as other employees generally.  The agreement includes customary restrictive covenants, including confidentiality and non-solicitation covenants and a one-year post-employment non-compete restriction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing does not purport to be a complete description of the Employment Agreement and is qualified in its entirety by reference to the full text of such agreement, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">     </span></div><div><span><br/></span></div><div id="ifc6a2a7c0e21475291330a18192bb8ae_10"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01.            Regulation FD Disclosure. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On October 20, 2025, the Company issued a press release announcing the appointment of Mr. LaCamp to the Board.  A copy of such press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div id="ifc6a2a7c0e21475291330a18192bb8ae_13"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:justify"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(d)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:15.34pt">Exhibits     The following exhibits are being filed herewith:</span></div><div style="margin-top:10pt;padding-left:54pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-xcampbellemploymentag.htm">Interim Executive Employment Agreement, dated October 20 2025, between the Company and Leslie C.G. Campbell</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-jameslacamppressrelea.htm">Press release dated October 20, 2025</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">3</span></div></div></div><div id="ifc6a2a7c0e21475291330a18192bb8ae_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Dated: October 21, 2025</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">PETMED EXPRESS, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">/s/ Robert Lawsky</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Name:</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Robert Lawsky</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">General Counsel</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">4</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>pets-xcampbellemploymentag.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ided926b67ef24b5987fdb3fd6baddd8a_1"></div><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-left:8.97pt;padding-right:8.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">INTERIM EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-top:11.75pt;padding-right:17.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">THIS INTERIM EXECUTIVE EMPLOYMENT AGREEMENT (hereinafter &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made and entered into effective as of October 20, 2025, by and between PETMED EXPRESS, INC., a Florida corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and LESLIE C. G. CAMPBELL, an individual residing in the State of Florida (hereinafter called &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:12.25pt;padding-left:8.97pt;padding-right:8.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">RECITALS</font></div><div style="margin-top:7.65pt;padding-right:17.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, Company desires to retain the services of Executive as Interim Chief Executive Officer and President of Company upon the terms and subject to the conditions set forth in this Agreement&#59; and</font></div><div style="margin-top:12.05pt;padding-right:18.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, Executive desires to provide services to Company pursuant to the terms and conditions set forth in this Agreement</font></div><div style="margin-top:12pt;padding-right:17.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">NOW THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, in consideration of the mutual covenants and promises set forth in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, agree as follows&#58;</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">DUTIES AND SCOPE OF EMPLOYMENT</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-right:17.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Position and Duties</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. During the Term of Employment (as defined below), Executive shall be employed by Company on an at-will basis as its Interim Chief Executive Officer and President, reporting to the Board of Directors of Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). As Interim Chief Executive Officer and President, Executive shall have such duties, powers, and responsibilities as are customarily assigned to a chief executive officer and president of a publicly held corporation. In addition, Executive shall have such other duties and responsibilities as the Board may reasonably assign to her from time to time that are commensurate with and customary for a senior executive officer bearing Executive&#8217;s experience, qualifications, title, and position. Executive&#8217;s employment by Company shall be full- time, and Executive agrees to diligently and conscientiously devote all of her business time and attention to the performance of Executive&#8217;s duties hereunder and will not engage in any other business, profession, occupation, or activity for compensation&#59; provided she may serve on the board of directors of one or more other companies or organizations with the specific prior written approval of the Board and only as long as serving on such boards does not prevent her from effectively and competently performing her duties under this Agreement.  Company hereby consents Executive&#8217;s continued service on the boards of directors of PointClickCare and Bideawee, so long as such continued service</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">does not prevent her from effectively and competently performing her duties under this Agreement.  Nothing herein shall prohibit or restrict Executive from managing Executive&#8217;s own personal investments and&#47;or engaging in civic, community, charitable, educational, religious, or non-profit activities as long as such activities do not materially interfere with Executive&#8217;s performance of her duties to Company as provided in this Agreement. As Interim Chief Executive Officer and President, Executive will serve as Company&#8217;s &#8220;principal executive officer&#8221; for purposes of the rules and regulations of the Securities and Exchange Commission during the Term of Employment.</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12.1pt;padding-right:17.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Location of Employment Services</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive will spend substantially all of her business time working from Company&#8217;s principal executive offices currently located in Delray Beach, Florida, subject to the reasonable travel needs associated with her duties.</font></div><div style="margin-top:12pt;padding-right:17.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Subsidiaries and Affiliates</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. With respect to Company&#8217;s direct and indirect subsidiaries, affiliated corporations, partnerships, or joint ventures (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Related</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Entities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Executive shall perform the above-described duties to promote these Related Entities and to promote and protect their respective interests to the same extent as the interests of Company without additional compensation. This shall include serving, at the direction of the Board, as an officer or on the board of directors of Related Entities.</font></div><div style="margin-top:12pt;padding-right:17.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Service on Board of Directors&#59; Position of Board Chair</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive is a member of the Board, and Company shall, throughout the Term of Employment, nominate and recommend her election as member of the Board to the shareholders of Company.  Executive shall continue to serve as Chair of the Board for no additional consideration, and her service as Chair shall continue until the earlier of her resignation or removal from that position or until her successor is duly elected.   Nothing in this Agreement shall be construed as prohibiting the Board from removing or replacing Executive as Chair of the Board during or after the Term of Employment, and such removal or replacement shall not be deemed to be a termination of Executive&#8217;s employment hereunder. </font></div><div style="margin-top:12.05pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">COMPENSATION</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-right:17.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. During the Term of Employment, Executive shall be paid a base salary of One Million Three Hundred Thousand Dollars ($1,300,000) per year, pro-rated for any period less than twelve (12) months (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Base Salary will be paid in accordance with Company&#8217;s customary payroll procedures and will be subject to tax and other applicable withholdings. The Base Salary may be increased by the Board (in its sole and absolute discretion), but not decreased, unless otherwise agreed to in writing by Executive or except in the case of a proportionate reduction in salary and wages of the senior management of Company.</font></div><div style="margin-top:12.05pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Benefits</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive is eligible to receive such medical, health, and other benefits as are provided by Company, in its discretion, from time to time to its employees generally. Executive will also be eligible to participate in Company&#8217;s 401(k) plan on the same basis as Company&#8217;s employees generally. Nothing in this Agreement will preclude Company from amending or terminating any of the employee benefit plans or programs applicable to employees of Company as long as such amendment or termination is applicable to all similarly-situated employees.</font></div><div style="margin-top:12pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Vacation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive will receive four (4) weeks of vacation each calendar year, with such period prorated for the period of time she is employed for partial calendar years.  </font></div><div style="margin-top:12pt;padding-right:17.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Company shall be entitled to deduct or withhold from any amounts owing from Company to Executive any federal, state, local or foreign withholding taxes, excise taxes or employment taxes imposed with respect to Executive&#8217;s compensation or other payments </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-right:17.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">from Company, including wages, bonuses, distributions and&#47;or the receipt or vesting of incentive equity.</font></div><div style="margin-top:12pt;padding-right:17.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Reimbursement of Business Expenses</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive shall be entitled to reimbursement for all reasonable and necessary out-of-pocket business, entertainment, and travel expenses incurred by Executive in connection with the performance of Executive's duties hereunder in accordance with Company's expense reimbursement policies and procedures and such other applicable policies and procedures as may be in effect from time to time, including without limitation any travel and expense policy and any code of conduct or code of ethics.</font></div><div style="margin-top:12.05pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.08pt;text-decoration:underline">Clawback Provisions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any other provisions in this Agreement to the contrary, any bonus (if any) and other compensation paid to Executive will be subject to such potential clawback as may be required to be made pursuant to applicable federal or state law, or pursuant to applicable stock exchange listing requirements, governing potential clawback of executive compensation upon a determination by legal counsel to Company that clawback is required by federal or state law or applicable stock exchange listing requirements. Specifically, Executive agrees that she will be subject to, and shall comply with, the PetMed Express, Inc. Executive Compensation Recovery Policy.</font></div><div style="margin-top:12pt;padding-right:17.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">TERM OF EMPLOYMENT</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive&#8217;s employment commenced on August 11, 2025 and shall continue under this Agreement until, and including, August 10, 2026, unless terminated earlier in accordance with Section 4 of this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Term of Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">TERMINATION</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive&#8217;s employment by Company is on an &#8220;at-will&#8221; basis and may be immediately terminated at any time (including prior to the scheduled expiration of the Term of Employment) and for any reason (with or without cause) by Company or Executive by delivering written notice of termination to the other party.</font></div><div style="margin-top:12pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Effect of Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">In the event of the termination of Executive&#8217;s employment for any reason, Executive (or Executive&#8217;s legal representative) shall be entitled to receive (i) on the next payroll date, wages in an amount equal to any earned but unpaid Base Salary owing by Company to Executive as of the termination date&#59; and (ii) within the normal course, reimbursement for her business expenses incurred before the termination date as determined under Section 2(e).  </font></div><div style="margin-top:12pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Other Matters</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Upon termination of Executive&#8217;s employment for any reason, Executive shall be deemed to have resigned, and does hereby resign, from all officer positions with the Company and all positions and directorships held with the Related Entities.  Upon request of Company, Executive shall promptly sign and deliver to Company any and all documents reflecting such resignations as of the effective date of termination.  Notwithstanding the foregoing, upon termination of Executive&#8217;s employment, Executive shall not be deemed to have resigned, and does not hereby resign, from her position as a director of the Company (nor from her position as Chair of the Board, if she is still Chair at such time), unless otherwise agreed to by Executive in writing. </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">NON-COMPETITION, NON-SOLICITATION AND CONFIDENTIALITY</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-right:17.9pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company&#8217;s Business</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the online sale, marketing, or distribution of (i) prescription and non-prescription pet medications or health products or services, or (ii) foods, beverages, or supplies for dogs, cats, and horses.</font></div><div style="margin-top:12.05pt;padding-right:17.9pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Competitor</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any company, other entity, or association or individual that directly or indirectly engages in Company&#8217;s Business.</font></div><div style="margin-top:12pt;padding-right:17.7pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any information with respect to Company or any Related Entity or Company&#8217;s Business, including, but not limited to&#58; the trade secrets of Company and any Related Entities&#59; manuals and documentation&#59; databases&#59; Company&#8217;s and any Related Entity&#8217;s existing and prospective clients and customers, sales lists, supplier and vendor lists, marketing plans, business plans, industry information acquired or prepared by Company, product specifications, product ideas, price lists, and other similar and related information in whatever form. The term &#8220;Confidential Information&#8221; does not include, and there shall be no obligation hereunder with respect to, information that is generally available or becomes generally available to the public other than as a result of a disclosure by Executive not otherwise permissible hereunder.</font></div><div style="margin-top:12pt;padding-right:17.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Non-competition</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive covenants and agrees that during the period of her employment with Company and during the Restricted Period (as defined below), Executive will not engage in or participate in Company&#8217;s Business or own, manage, engage in, participate in (on behalf of herself or any other person or entity), operate, control, become employed by, or render any service to (whether as owner, beneficial owner, partner, associate, agent, independent contractor, consultant, lender, employee, stockholder, director or officer or in any other capacity), or invest in any Competitor anywhere in the United States of America or Canada or any other place outside of the United States of America in which Company markets, sells, or distributes products. Notwithstanding the foregoing, nothing in this paragraph shall prohibit Executive from owning 2% or less of the stock of any public traded company. The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the twelve (12)-month period immediately following the termination of Executive&#8217;s employment with Company, regardless of the reason for termination and regardless of who effects the termination. Notwithstanding the foregoing, nothing in this paragraph will prohibit Executive from being employed by or rendering services to a business enterprise with multiple separately managed business units (one or more of which engages in Company&#8217;s Business) so long as (i) Executive does not work in or provide services to the business unit that engages in Company&#8217;s Business, (ii) the business unit that engages in Company&#8217;s Business is not the principal business unit of the business enterprise&#59; and (iii) Executive otherwise complies with the terms of this Agreement and does not engage in activities that actually or potentially competes with Company&#8217;s Business.</font></div><div style="margin-top:12pt;padding-right:17.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Non-solicitation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive covenants and agrees that, during the Restricted Period, she will not on Executive&#8217;s own behalf or on behalf of any other person or entity, (A) hire, cause to be hired, or solicit or attempt to solicit the employment of any person who was </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-right:17.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">employed by Company or any Related Entity at any time during the one (1)-year period immediately preceding the Restricted Period, or seek to persuade any employee of Company to discontinue employment, (B) solicit or encourage any customer, client or supplier of Company or any independent contractor providing services to Company to terminate or diminish its relationship with Company, (C) seek to persuade any customer, client or supplier, or prospective customer, client or supplier, of Company to conduct with anyone else any business or activity that such customer, client or supplier, or prospective customer, client or supplier, conducts or could conduct with Company or any Related Entity, or (D) solicit or encourage any person or entity that has or does refer business to Company for the purpose of having such person or entity refer business to a competing business.</font></div><div style="margin-top:12.05pt;padding-right:17.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Representations and Covenants by Executive</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive represents and warrants that&#58; (i) Executive&#8217;s execution, delivery and performance of this Agreement do not and will not conflict with, breach, violate or cause a default under any contract, agreement, instrument, order, judgment or decree to which Executive is a party or by which Executive is bound&#59; (ii) Executive is not a party to or bound by any employment agreement noncompete agreement with any other person or entity (other than Company) or other agreement that would prevent or in any manner restrict Executive from performing Executive&#8217;s duties for Company or otherwise complying with this Agreement&#59; (iii) Executive is not in breach of and will not breach any nondisclosure agreement with any third party, including any agreement concerning trade secrets or confidential information owned by any other party&#59; and (iv) upon the execution and delivery of this Agreement by Company, this Agreement shall be the valid and binding obligation of Executive, enforceable in accordance with its terms.</font></div><div style="margin-top:12.05pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Non-disclosure of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive hereby acknowledges and represents that Executive fully understands the terms and conditions contained herein and Executive agrees that Executive will not, directly or indirectly&#58;</font></div><div style="padding-right:17.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(i) use, disclose, reverse engineer or otherwise exploit for Executive&#8217;s own benefit or for the benefit of anyone other than Company the Confidential Information except as authorized by Company&#59; (ii) during Executive&#8217;s employment with Company, use, disclose, or reverse engineer</font></div><div style="padding-right:17.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(x) any confidential information or trade secrets of any former employer or third party, or (y) any works of authorship developed in whole or in part by Executive during any former employment or for any other party, unless authorized in writing by the former employer or third party&#59; or (iii) upon Executive&#8217;s resignation or termination (x) retain Confidential Information, including any copies existing in any form (including electronic form), that are in Executive&#8217;s possession or control, or</font></div><div style="padding-right:17.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(y) destroy, delete or alter the Confidential Information without Company&#8217;s consent. Notwithstanding the foregoing, Executive may use the Confidential Information in the course of performing Executive&#8217;s duties on behalf of Company or any Related Entity provided that such use is made in good faith and on a reasonable basis. Notwithstanding the terms of this Agreement, Confidential Information may be disclosed by Executive when and to the limited extent compelled by written notice from a government agency or when and to the limited extent compelled by legal process or court order by a court of competent jurisdiction, provided that, to the extent legally permissible, Executive shall give Company prompt written notice of such request or order and the Confidential Information to be disclosed as far in advance of its disclosure as possible so that Company may seek an appropriate protective order. Upon </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-right:17.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">separation of employment or suspension (for any reason), Executive will immediately surrender possession of all Confidential Information to Company. Nothing in this Agreement is intended to discourage or restrict Executive from reporting any theft of trade secrets pursuant to the Defend Trade Secrets Act of 2016 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DTSA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or other applicable state or federal law. The DTSA prohibits retaliation against an employee because of whistleblower activity in connection with the disclosure of trade secrets, so long as any such disclosure is made either (i) in confidence to an attorney or a federal, state, or local government official and solely to report or investigate a suspected violation of the law, or (ii) under seal in a complaint or other document filed in a lawsuit or other proceeding. In addition, nothing contained in this Agreement shall be deemed to prevent Executive from disclosing any information or facts concerning matters Executive reasonably believes to be illegal discrimination, illegal harassment&#59; illegal retaliation&#59; a wage and hour violation&#59; sexual assault&#59; or acts recognized as against a clear public policy mandate.</font></div><div style="margin-top:12.05pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.08pt;text-decoration:underline">Inventions and Patents</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive acknowledges that all (i) inventions, innovations, improvements, developments, methods, designs, analysis, drawings, reports, processes, novel concepts, ideas, copyrights, trademarks and service marks relating to any present or prospective activities of Company, including but not limited to marketing plans or techniques, processes, software, formula, techniques and improvements to the foregoing or to know how, and all similar or related information (whether or not patentable) that relate to Company&#8217;s Business, (ii) research and development and (iii) existing or future products or services that are, to any extent, conceived, developed or made by Executive while employed by Company or any Related Entity (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Work</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Product</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) belong to Company or such Related Entity. Executive shall promptly disclose such Work Product to Company and, at the cost and expense of Company, perform all actions reasonably necessary or requested by Company (whether during or after the Term of Employment) to establish and confirm such ownership (including, without limitation, executing assignments, consents, powers of attorney and other instruments.  Executive hereby assigns and agrees to assign automatically without requirement of further writing when first reduced to practice or recorded in a tangible medium, without royalty or other further consideration, to the Company all of Executive&#8217;s right, title, and interest, including all rights of copyright, patent, semiconductor mask protection, and other intellectual property rights, to or in such Work Product.</font></div><div style="margin-top:12.05pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Trade Secrets&#47;Defend Trade Secrets Act</font><font style="color:#222222;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Nothing</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> in this Agreement diminishes or limits any protection granted by law to trade secrets, or relieves Executive of any duty not to disclose, use, or misappropriate any </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">information </font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">that is a trade secret, for as long as such information remains a trade </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">secret</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Additionally, nothing in this Agreement is intended to discourage Executive from reporting any </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">theft</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> of trade </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">secrets</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> to the appropriate government official pursuant to the Defend Trade Secrets Act of 2016 (&#8220;</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DTSA</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or other applicable state or federal law. Additionally, under the DTSA, a trade secret may be disclosed to report a suspected violation of law and&#47;or in an anti-retaliation lawsuit, as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i) </font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that&#58; (A) is made (1) in confidence to a Federal, State, or local government </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">official</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, either directly or indirectly, or to an attorney&#59; and (2) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">under seal.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(ii) A</font><font style="color:#222222;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">n individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual&#58; (A) files any document containing the trade secret under seal&#59; and (B) does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement shall limit, curtail or diminish the Company&#8217;s statutory rights under the DTSA, any applicable state law regarding trade secrets or common law</font></div><div style="margin-top:12.05pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Acknowledgements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:17.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Executive acknowledges that (x) Executive&#8217;s position is a position of trust and responsibility with access to Confidential Information of Company, (y) the Confidential Information, and the relationship between Company and each of its employees, customers, tenants, and vendors, are valuable assets of Company and may not be converted to Executive&#8217;s own use and (z) the restrictions contained in this Section 5 are reasonable and necessary to protect the legitimate business interests of Company and will not impair or infringe upon Executive&#8217;s right to work or earn a living after Executive&#8217;s employment with Company ends.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:17.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Executive acknowledges that monetary damages will not be an adequate remedy for Company in the event of a breach of this Agreement and that it would be impossible for Company to measure damages in the event of such a breach. Therefore, Executive agrees that, in addition to other rights that Company may have at law or equity, Company is entitled to seek an injunction preventing Executive from any breach of this Agreement.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:17.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">In the event of a breach or violation of any restriction in Section 5(b) or 5(c) of this Agreement, the time limitations set forth in such restriction shall be extended for a period of time equal to the period of time until such breach or violation has been cured.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:17.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">The parties agree that the foregoing restrictive covenants are reasonable and necessary to protect Company&#8217;s legitimate business interests. The parties, however, do not intend to include a provision that contravenes the public policy of any state. Therefore, if any provision of this Section 5 is unlawful, against public policy or otherwise declared void, such provision shall not be deemed part of this Agreement, which otherwise shall remain in full force and effect. If, at the time of enforcement of this Agreement, a court or other tribunal holds that the duration, scope or area restriction stated herein is unreasonable under the circumstances then existing, the parties agree that the court should enforce the restrictions to the extent it deems reasonable.</font></div><div style="margin-top:12.05pt;padding-left:36pt;padding-right:17.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Executive hereby agrees that prior to accepting employment with any other person or entity during the term of employment or during the Restricted Period following the termination date, Executive will provide such prospective employer with </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12.05pt;padding-left:36pt;padding-right:17.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">written notice of the existence of this Agreement and the provisions of this Section 5 of this Agreement, with a copy of such notice delivered simultaneously to Company in accordance with Section 8 of this Agreement.</font></div><div style="margin-top:12pt;padding-left:36pt;padding-right:17.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">Notwithstanding any provision of this Agreement, the obligations and commitments of this Section 5 shall survive and continue in full force and effect in accordance with their terms notwithstanding any termination of Executive&#8217;s employment for any reason or termination of this Agreement for any reason.</font></div><div style="margin-top:12pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">REMEDIES</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive agrees and acknowledges that a breach on the part of Executive of the covenants contained in Section 5 may cause irreparable harm to Company and that damages arising out of such breach may be difficult to determine. Executive, therefore, further agrees that in addition to all other remedies provided at law or at equity, Company shall be entitled to seek specific performance and temporary and permanent injunctive relief, from any court of competent jurisdiction restraining any further breach of any such covenant by Executive, her employers, employees, partners, agents or other associates, or any of them, without the necessity of proving actual damage to Company by reason of any such breach.</font></div><div style="margin-top:12.05pt;padding-right:17.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">ASSIGNMENT</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Company may assign this Agreement and any of the rights or obligations hereunder to any third party in connection with the sale, merger, consolidation, reorganization, liquidation or transfer, in whole or in part, of Company&#8217;s control and&#47;or ownership of its assets or business. In such event, Executive continues to be bound by the terms of this Agreement. An assignment of this Agreement by Executive or any right or obligation hereunder is strictly prohibited.</font></div><div style="margin-top:12pt;padding-right:17.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">NOTICES</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. All notices and other communications provided to either party hereto under this Agreement shall be in writing and delivered by certified or registered mail, postage prepaid, by e-mail if also sent via first class U.S. mail, or by national overnight delivery service (such as Federal Express), to such party at its&#47;her address set forth below, or at such other address as may be designated by either party in conformity with the provisions of this Section 8, with any such notices being deemed given when actually received by the recipient&#58;</font></div><div style="margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If to Company&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">c&#47;o PetMed Express, Inc.</font></div><div style="padding-left:162.05pt;padding-right:157.4pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">420 South Congress Avenue Delray Beach, FL 33445</font></div><div style="padding-left:162.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">E-mail&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">rlawsky&#64;petmeds.com</font></div><div style="margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">If to Executive&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">To Executive&#8217;s address as reflected on the payroll records of</font></div><div style="padding-left:162.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Company</font></div><div style="margin-top:12.05pt;padding-right:17.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement shall be subject to and governed by the laws of the State of Florida, without giving effect to the principles of conflicts of law under Florida law that would require or permit the application of the laws of a jurisdiction other than the State of Florida and irrespective of the fact that the parties now or at any time may be residents of or engage in activities in a different state.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">DISPUTE RESOLUTION</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-right:17.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.75pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Company and Executive agree that any dispute, controversy or claim arising out of or related in any way to Executive&#8217;s employment relationship with Company, the termination of that relationship, this Agreement, and&#47;or any breach of this Agreement, shall be submitted to and decided by binding arbitration in Palm Beach County in the State of Florida. By accepting employment with Company, Executive accepts and consents to be bound by this agreement to arbitrate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Arbitration Provision</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). This Arbitration Provision covers all grievances, disputes, claims or causes of action that otherwise could be brought in a federal, state or local court under applicable federal, state or local laws, arising out of or relating to Executive&#8217;s employment with Company and the termination thereof, including claims Executive may have against Company or against its officers, directors, supervisors, managers, employees or agents in their capacity as such or otherwise. The claims covered by this Arbitration Provision include, but are not limited to, claims for breach of any contract or covenant (express or implied)&#59; tort claims&#59; claims for wages or other compensation due&#59; claims for wrongful termination (constructive or actual)&#59; claims for discrimination or harassment (including, but not limited to, harassment or discrimination based on race, age, color, sex, gender, national origin, alienage or citizenship status, creed, religion, marital status, partnership status, military status, predisposing genetic characteristics, medical condition, psychological condition, mental condition, criminal accusations and convictions, disability, sexual orientation, or any other trait or characteristic protected by federal, state or local law)&#59; claims for violation of any federal, state, local or other governmental law, statute, regulation or ordinance&#59; and claims or disputes concerning the validity, enforceability, arbitrability or scope of this Arbitration Provision. Claims not covered by this Arbitration Provision are claims for workers&#8217; compensation or unemployment compensation benefits&#59; at Company&#8217;s sole option, claims by Company for injunctive or other equitable relief for the breach or threatened breach of the covenants above&#59; and any other claims that, as a matter of law, Company and Executive cannot agree to arbitrate. Nothing herein shall impair Executive&#8217;s right to report possible violations of law to any government agency or cooperate with any agency&#8217;s investigation.</font></div><div style="margin-top:12pt;padding-right:17.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Company and Executive expressly intend and agree that&#58; (a) class, collective and&#47;or representative action procedures shall not be asserted, nor will they apply, in any arbitration pursuant to this Arbitration Provision&#59; (b) Executive will not assert class, collective and&#47;or representative action claims against Company or its officers, directors, supervisors, managers, employees or agents in arbitration or otherwise&#59; and (c) Executive shall only submit her own, individual claims in arbitration and will not seek to represent the interests of any other person. Further, Company and Executive expressly intend and agree that any claims by Executive will not be joined, consolidated or heard together with claims of any other employee.</font></div><div style="margin-top:12pt;padding-right:17.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Arbitrator shall apply the substantive law of the State of Florida or federal law (and the law of remedies, if applicable) as applicable to the claims asserted and shall apply the same rules of evidence as a federal court. Arbitration shall be administered in accordance with the AAA Employment Arbitration Rules in effect at the time the arbitration is commenced. To the extent not provided for in the AAA Employment Arbitration Rules, the Arbitrator has the power to order discovery upon a showing that discovery is necessary for a party to have a fair opportunity to present a claim or defense, and the Arbitrator shall decide all discovery disputes. Executive&#8217;s agreements to arbitrate and participate only in her individual capacity are contracts under the Federal Arbitration Act and any other laws validating such agreements. No failure to </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;padding-right:17.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">strictly enforce these agreements will constitute a waiver or create any future waivers. If any part of this Arbitration Provision is adjudged to be void or otherwise unenforceable, in whole or in part, the void or unenforceable portion shall be severed and such adjudication shall not affect the validity of the remainder of this Arbitration Provision and&#47;or this Agreement. Any arbitral award determination shall be final and binding upon the parties. Judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.</font></div><div style="margin-top:12.05pt;padding-right:17.55pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, any claims or actions, whether for damages, injunctive relief or other relief, for any violation or breach of the covenants set forth in Section 5 and the remedies set forth in Section 6, including but not limited to the actions described in Section 6, (i) shall be excluded from the Arbitration Provision and its applicability, and (ii) shall be resolved exclusively in the State of Florida in the state courts located in Palm Beach County, Florida or in the United States District Court for the Southern District of Florida.</font></div><div style="margin-top:12.05pt;padding-right:17.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.07pt;text-decoration:underline">Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing in the Arbitration Provision and&#47;or this Agreement shall prevent Company from applying to and obtaining from a court of competent jurisdiction a writ of attachment, a temporary restraining order, a permanent restraining order, a temporary injunction, a permanent injunction, or other injunctive relief available to safeguard and protect Company&#8217;s interests, including but not limited to Company&#8217;s interests in the restrictive covenants contained herein. Any action, suit or other proceeding initiated for these purposes shall be brought in the State of Florida in the state courts located in Palm Beach County, Florida or in the United States District Court for the Southern District of Florida and Executive agrees to submit herself to the exclusive personal jurisdiction and venue of those courts for such purposes.</font></div><div style="margin-top:4.2pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.75pt;text-decoration:underline">WAIVER OF JURY TRIAL. COMPANY AND EXECUTIVE</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">UNDERSTAND AND AGREE THAT THEY ARE WAIVING ANY RIGHT TO JURY TRIAL WITH RESPECT TO ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF OR RELATED IN ANY WAY TO EXECUTIVE&#8217;S EMPLOYMENT RELATIONSHIP WITH COMPANY, THE TERMINATION OF THAT RELATIONSHIP, THIS AGREEMENT, AND&#47;OR ANY BREACH OF THIS AGREEMENT. COMPANY AND EXECUTIVE EXPRESSLY ACKNOWLEDGE AND AGREE THAT THEY ARE WAIVING ANY RIGHT THEY MAY HAVE TO A JURY TRIAL BY SIGNING THIS AGREEMENT.</font></div><div style="margin-top:11.8pt;padding-right:18.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.05pt;text-decoration:underline">INVALIDITY</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Any provision herein which in any way contravenes the applicable laws of any country, state or jurisdiction shall be severed from this Agreement and deemed not to be considered part of this Agreement and this Agreement shall not be invalid as a whole because of any such determination.</font></div><div style="margin-top:12.05pt;padding-right:18pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.05pt;text-decoration:underline">INDULGENCE</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. No indulgence extended by either party hereto to the other party shall be construed as a waiver of any breach on the part of such other party, nor shall any waiver of one breach be construed as a waiver of any rights or remedies with respect to any subsequent breach.</font></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">ENTIRE AGREEMENT AND CHANGES TO BE IN WRITING</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;Except as</font></div><div style="padding-right:17.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">otherwise indicated herein, this Agreement shall constitute the entire agreement between Executive and Company concerning the subject matter hereof. This Agreement supersedes and </font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="padding-right:17.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">preempts any prior employment agreement or other understandings, agreements or representations by or among the parties, written or oral, that may have related to the subject matter hereof. No provisions of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing, signed by Executive and an authorized officer of Company.</font></div><div style="margin-top:12pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.05pt;text-decoration:underline">NON-DISPARAGEMENT</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive agrees to not make any statements, written or oral, while employed by Company and thereafter, which would be reasonably likely to disparage or damage Company and its Related Entities or the personal or professional reputation of any present or former employees, officers or members of the managing or directorial boards or committees of Company or the Related Entities. This Section 14 shall not prohibit Executive from making truthful statements in connection with a legal proceeding or in response to a reference request, and nothing in this Section 14 prohibits Executive from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Executive has reason to believe is unlawful.</font></div><div style="margin-top:12.05pt;padding-right:17.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.05pt;text-decoration:underline">STRICT COMPLIANCE</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Executive&#8217;s or Company&#8217;s failure to insist upon strict compliance with any provision of this Agreement or the failure to assert any right Executive or Company may have hereunder shall not be deemed to be a waiver of such provision or right or any other provision or right of this Agreement. The waiver, whether express or implied, by either party of a violation of any of the provisions of this Agreement shall not operate or be construed as a waiver of any subsequent violation of any such provision.</font></div><div style="margin-top:12pt;padding-right:17.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.05pt;text-decoration:underline">SURVIVAL</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. Any provision of this Agreement that is expressly or by implication intended to survive the termination of this Agreement shall survive or remain in effect after the termination of this Agreement.</font></div><div style="margin-top:12pt;padding-right:17.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.05pt;text-decoration:underline">COUNTERPARTS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may be executed in separate counterparts, either one of which need not contain the signature of more than one party, but both such counterparts taken together shall constitute one and the same agreement. Counterparts may be delivered via facsimile, electronic mail (including .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</font></div><div style="margin-top:12.05pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">UNDERSTANDING OF EXECUTIVE&#59; CONSULTATION WITH COUNSEL.</font></div><div style="padding-right:17.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive represents to Company that Executive has read this Agreement in its entirety, that Executive understands it and that Executive has entered into it voluntarily. Executive hereby further acknowledges and represents that Executive has had the opportunity to consult with independent legal counsel regarding Executive&#8217;s rights and obligations under this Agreement and that Executive fully understands the terms and conditions contained herein, including without limitation the obligations, restrictions, and provisions set forth in Section 5, 6, 9, and 10 of this Agreement.</font></div><div style="margin-top:12pt;padding-left:8.95pt;padding-right:8.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#91;signatures follow&#93;</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:66.96pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4pt;padding-right:21.55pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> WHEREOF, the parties intending to be legally bound have executed this Interim Executive Employment Agreement as of the date first set forth above.</font></div><div><font><br></font></div><div style="padding-left:216.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">PETMED EXPRESS, INC.</font></div><div><font><br></font></div><div style="padding-left:252.05pt;padding-right:42.7pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; _&#47;s&#47; Robert Lawsky_______________<br>Robert Lawsky</font></div><div style="padding-left:252.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">General Counsel</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:216.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">EXECUTIVE</font></div><div><font><br></font></div><div style="padding-left:252.05pt;padding-right:30.7pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; _&#47;s&#47; Leslie C.G. Campbell__________<br>Leslie C.G. Campbell, individually</font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>pets-jameslacamppressrelea.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i0864cb85921a4180a09e62accbd0ed70_1"></div><div style="min-height:77.76pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:125%">Fourth independent director to join the board since 2024</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">DELRAY BEACH, Fla., October 20, 2025 -- PetMed Express, Inc., d&#47;b&#47;a PetMeds and parent company of PetCareRx, (Nasdaq&#58; PETS) (the &#8220;Company&#8221;), today announced the appointment, effective immediately, of James LaCamp to the Company&#8217;s Board of Directors (the &#8220;Board&#8221;), and effective October 30, Mr. LaCamp will become  Chair of the Audit Committee of the Board.  Mr. LaCamp also qualifies as an &#8220;audit committee financial expert&#8221; within the meaning of the SEC&#8217;s rules and regulations. Mr. LaCamp brings close to two decades of experience in finance, accounting, audit, and corporate strategy roles, including currently as a Chief Financial Officer.  Previously, he spent over 12 years at Deloitte &#38; Touche LLP, where he served as Audit Partner to clients ranging from high-growth private companies to complex Fortune 50 public companies and as the Software Leader of Deloitte &#38; Touche&#8217;s U.S. Technology Industry Practice. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">&#8220;James is an outstanding addition to our Board, and we are thrilled to welcome him as a director immediately and later this month as the Chair of our Audit Committee,&#8221; said Leslie C. G. Campbell, Chair of the Board. &#8220;He is a proven leader with a successful track record, and his appointment reinforces our commitment to strong oversight, transparency and financial governance. His expertise in audit, accounting, finance, internal controls, risk management, corporate strategy, and business operations was of particular interest to our Board in considering James&#8217; candidacy and will be critical to our efforts to responsibly pursue the scaling of our business and drive sustainable, profitable revenue growth. That expertise, combined with his lengthy and successful tenure serving as a director and audit committee chair at another technology-driven public company, makes him ideal to serve as the chair of our Audit Committee. I am confident that James will be instrumental in strengthening our financial governance, transparency, and board oversight functions.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Mr. LaCamp&#8217;s appointment to the Board is consistent with the Company&#8217;s ongoing board composition evaluation and refreshment activities.  This reflects the Company&#8217;s continuing commitment to build a board of independent and highly qualified directors that have the critical experience, skills, and perspectives that support the Company&#8217;s strategy for pursuing profitable revenue growth and shareholder value creation. Other notable changes and enhancements to the board since fiscal Q4 2024 include Ms. Campbell assuming the role of Chair of the Board at the beginning of fiscal Q4 2024, followed in fiscal Q2 2025 by the appointment to the Board of Justin Mennen, Chief Information and Technology Officer at Shake Shack, and Leah Solivan, founder of TaskRabbit.  Peter Batushansky, formerly CEO of Allivet, joined the Board in fiscal Q1 2026. The Board is now comprised of six highly qualified and experienced directors, five of whom are independent and four of whom have been added since 2024. </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">&#34;I'm delighted to join the PetMeds Board at this critical juncture,&#34; said Mr. LaCamp. &#34;From its founding nearly 30 years ago as a pioneer online pet pharmacy, PetMeds has built a solid platform for serving the needs of pets and pet parents and is strategically well positioned for the future.  I'm looking forward to partnering with my board colleagues to ensure we have the right financial governance, internal controls, and oversight functions in place and remain transparent with our shareholders as we scale responsibly, and pursue growth, profitability, and shareholder value creation.&#8221;  </font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Ms. Campbell added &#8220;The appointment of James LaCamp to our Board, as well as the appointments of Justin Mennen, Leah Solivan, and Peter Batushansky over the past months, are the result of our strong ongoing focus on strategic Board composition and refreshment and our commitment to building a board that is a strategic asset for the creation of shareholder value.&#8221;</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">The Board has determined that Mr. LaCamp qualifies as an &#8220;independent director&#8221; as defined under Rule 5605(a)(2) of the Nasdaq Marketplace Rules. In addition to being named as Chair of the Audit Committee effective October 30, 2025, concurrently with being named to the Board effective immediately, Mr. LaCamp has also been appointed as a member of the Board&#8217;s Audit Committee and of the Compensation and Human Capital Committee.</font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:77.76pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">About James LaCamp</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Mr. LaCamp has close to 20 years of experience in the accounting and finance sector, including serving in a key leadership role at one of the world&#8217;s four largest public accounting firms, where he oversaw audits at companies ranging from early-stage start-ups to Fortune 50 technology companies. Mr. LaCamp has also served in key leadership roles, including as Chief Financial Officer, at various technology companies.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Currently, Mr. LaCamp&#160;serves as the Chief Financial Officer of Skydio, a leading autonomous drone provider.  At Skydio, he is responsible for all aspects of the company&#8217;s financial operations, including accounting, information technology, security, and data &#38; analytics.  Prior to joining Skydio, Mr. LaCamp was Chief Financial Officer at Flock Safety, a safety technology provider. At Flock Safety, he oversaw the company's finance, corporate strategy, and business operations functions. Before joining Flock Safety, Mr. LaCamp was SVP Finance at Coupa Software, a leader in business spend management. At Coupa, he was involved in the company's financial strategy and operations including M&#38;A diligence and integration, FP&#38;A, internal controls, financial reporting, and sales operations. Before joining Coupa, Mr. LaCamp was an Audit Partner at Deloitte &#38; Touche LLP and the US Technology Industry Software Leader for Deloitte &#38; Touche LLP. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Since November 2019, Mr. LaCamp has served as a member of the Board of Directors of Performant Healthcare, Inc., which provides technology-driven audit, recovery, and analytics solutions to healthcare payers, the chair of its audit committee, and an &#8220;audit committee financial expert.&#8221; At Performant Healthcare, Mr. LaCamp also serves as a member of the compensation committee and the nominating and governance committee.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Mr. LaCamp holds a B.S.C. in Accounting from Santa Clara University and an M.B.A. from the Wharton School of Business at the University of Pennsylvania. He is also a licensed Certified Public Accountant in California and Washington.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">About PetMed Express, Inc.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PETS family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com. </font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:77.76pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">Forward Looking Statements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. Words such as &#8220;may,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;outlook,&#8221; &#8220;strategy,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;seek,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;strive,&#8221; &#8220;goal,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar words and expressions are intended to signify forward-looking statements.  These forward-looking statements include, without limitation, statements regarding the Company&#8217;s efforts to  leverage its brand and legacy as a pioneer in the digital pet pharmacy industry for nearly 30 years, enhance its operational execution, and build a platform for long-term value creation. Forward-looking statements are based on the Company&#8217;s current expectations and assumptions regarding future events, which are subject to risks and uncertainties. Actual results could differ materially from those anticipated due to a number of factors, including but not limited to, the results of the now completed investigation by the Audit Committee of the Company&#8217;s Board of Directors, the risk that the completion of the filing of the Company&#8217;s Quarterly Reports on Form 10-Q for the quarters ended June 30, 2025 and September 30, 2025 may take longer than expected, and other risks described from time to time in the Company&#8217;s filings with the Securities and Exchange Commission, including, but not limited to, the Company's Annual Report on Form 10-K for the year ended March 31, 2025, as well as other subsequent filings on Form 10-Q and periodic filings on Form 8-K. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release and should not be relied upon as representing the Company&#8217;s views as of any subsequent date. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">ICR, LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Reed Anderson</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">(646) 277-1260</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">investor&#64;petmeds.com</font></div><div><font><br></font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>pets-20251019.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b25d766c-3bfe-409e-b6e6-a74676f70a32,g:e571ee22-3a85-4a9d-aa25-d2857ed5c299-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pets="http://www.1800petmeds.com/20251019" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20251019">
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20251019_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20251019_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20251019_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.1800petmeds.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>pets-20251019_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b25d766c-3bfe-409e-b6e6-a74676f70a32,g:e571ee22-3a85-4a9d-aa25-d2857ed5c299-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20251019.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_ca5a59f5-785e-4535-a6f6-c974f9d3aa22" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_DocumentInformationTable_ca5a59f5-785e-4535-a6f6-c974f9d3aa22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b108e940-5d03-4346-8063-e4a2adda666c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_ca5a59f5-785e-4535-a6f6-c974f9d3aa22" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b108e940-5d03-4346-8063-e4a2adda666c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b108e940-5d03-4346-8063-e4a2adda666c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b108e940-5d03-4346-8063-e4a2adda666c" xlink:to="loc_us-gaap_ClassOfStockDomain_b108e940-5d03-4346-8063-e4a2adda666c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b108e940-5d03-4346-8063-e4a2adda666c" xlink:to="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_66c46225-a9f2-4f29-bb67-204d1b6aa095" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:to="loc_us-gaap_CommonStockMember_66c46225-a9f2-4f29-bb67-204d1b6aa095" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_6750377f-0849-48fb-a856-9bde4217fb78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:to="loc_us-gaap_PreferredStockMember_6750377f-0849-48fb-a856-9bde4217fb78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e213e1f4-3095-4605-a799-d4a99a84f61d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_DocumentType_e213e1f4-3095-4605-a799-d4a99a84f61d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_acab0ebe-8277-4d76-848d-114035d98e63" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_DocumentPeriodEndDate_acab0ebe-8277-4d76-848d-114035d98e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fc3a29b6-9331-4278-ba6b-f657baa3837d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityRegistrantName_fc3a29b6-9331-4278-ba6b-f657baa3837d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4a0c4664-37a0-40e7-9897-253d557d1dcc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4a0c4664-37a0-40e7-9897-253d557d1dcc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3bd588a1-02b0-4e6f-86cd-7e041326c37b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityFileNumber_3bd588a1-02b0-4e6f-86cd-7e041326c37b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_673350d4-a58b-45cb-990d-9e85ca6a25ff" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityTaxIdentificationNumber_673350d4-a58b-45cb-990d-9e85ca6a25ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_102b5612-45f8-4e09-8c28-fe7f735c57d2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressAddressLine1_102b5612-45f8-4e09-8c28-fe7f735c57d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5ba26a69-5f5a-4776-b696-da5988fab302" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressCityOrTown_5ba26a69-5f5a-4776-b696-da5988fab302" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4d7b2a98-8a49-4607-be45-f6bd46145a11" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressStateOrProvince_4d7b2a98-8a49-4607-be45-f6bd46145a11" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a55ed4e9-bcfc-40a3-bdcb-fb9a380b57c6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressPostalZipCode_a55ed4e9-bcfc-40a3-bdcb-fb9a380b57c6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_abef4ded-6e72-4efa-ab66-45d65b79312d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_CityAreaCode_abef4ded-6e72-4efa-ab66-45d65b79312d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1e13a244-e325-4331-a06e-07d3c021a243" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_LocalPhoneNumber_1e13a244-e325-4331-a06e-07d3c021a243" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_7ce1b514-cc95-4e75-be6a-315e9ad1c2b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_WrittenCommunications_7ce1b514-cc95-4e75-be6a-315e9ad1c2b1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_696d72e2-82a8-46a7-a5a0-01dc9fdc5663" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_SolicitingMaterial_696d72e2-82a8-46a7-a5a0-01dc9fdc5663" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_b08fdf78-0531-4b5c-b664-d24b1775b6a1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_PreCommencementTenderOffer_b08fdf78-0531-4b5c-b664-d24b1775b6a1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6cd82c31-38be-46ff-ab41-4d03d83b4848" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6cd82c31-38be-46ff-ab41-4d03d83b4848" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_262f4ae7-3b86-4d9b-aa8e-6620b350db2c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_Security12bTitle_262f4ae7-3b86-4d9b-aa8e-6620b350db2c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9936a717-3e74-4974-9ba4-660abfbcdc48" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_TradingSymbol_9936a717-3e74-4974-9ba4-660abfbcdc48" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dbc6c04e-3b05-4555-b727-025d780c8eaf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_SecurityExchangeName_dbc6c04e-3b05-4555-b727-025d780c8eaf" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_dd760837-dc71-4b23-bea9-de655eb93dfc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_NoTradingSymbolFlag_dd760837-dc71-4b23-bea9-de655eb93dfc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7bf936e8-36c3-4e14-a164-c0ca0402f156" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityEmergingGrowthCompany_7bf936e8-36c3-4e14-a164-c0ca0402f156" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_39725ebb-7108-4b11-a6b4-991898999b01" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityCentralIndexKey_39725ebb-7108-4b11-a6b4-991898999b01" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_eef70f82-f3fb-4099-a1fc-d0833cb0162b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_AmendmentFlag_eef70f82-f3fb-4099-a1fc-d0833cb0162b" xlink:type="arc" order="22"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>pets-20251019_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b25d766c-3bfe-409e-b6e6-a74676f70a32,g:e571ee22-3a85-4a9d-aa25-d2857ed5c299-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ClassOfStockDomain_f4752a2e-c373-4693-ba3a-f5c9f90ea080_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_82de1b23-3494-46f5-aa27-9fceb63d26d4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_f4a74c07-ff89-4b67-814c-e319696ca804_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ddf5940f-f084-4922-aebc-810ac5b20018_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_ff0b5d89-4869-4564-ba97-9a3f396317ff_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_763f4ca2-8f38-4548-a092-47827d147fcc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c1bd3b51-1846-4e24-a687-c7b490f5f58e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_aad1994e-8e5e-4f2e-829d-a07bc1c55335_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3fc17b49-3eb2-4a0f-b56b-088c508922b0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a0f4f655-4c95-44a6-b990-71eab3ed71f8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_898ea9cf-03cf-485b-8b93-7e7f2d3a9895_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8c79d992-8089-4458-82f7-2d862af2aec7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f4025e50-de5d-47c0-80af-afc38118952b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_0789eb23-04e5-49d1-96ed-a1a87524241b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e57f68b0-8ad3-445f-8a26-f82cf813e68a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_035ab531-9cf2-413d-b43b-d16c4d9703b7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c7230cc9-914f-4b99-b4e5-8a022a9d7a66_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_56dbd0f7-ca09-4c8c-bd24-65695486f796_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e63cfc34-6b7b-4d6d-8f68-a8150a857a39_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_8c9d2839-5476-4693-a19b-179779466b20_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_dc889455-fb38-4e33-9202-83636fdeb838_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_7d104ae7-96fe-4eaf-a07e-afef6db84e17_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_07bc1e74-6fe1-4269-ae87-0aaa31fbf117_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_278be78c-f31c-43b7-a1a0-6289489340ce_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_df23e403-1a53-4010-bf96-076e0a9d3bf8_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_412e316f-e74d-4860-a794-543fb25baa59_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0d8f62f6-1dcc-4754-a432-eb9c69c49768_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_cee71deb-65ae-46c3-ba70-a8bbf041e695_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f3d9f6ce-be5c-4f70-a0e8-d70ede87feb9_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>pets-20251019_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b25d766c-3bfe-409e-b6e6-a74676f70a32,g:e571ee22-3a85-4a9d-aa25-d2857ed5c299-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20251019.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_afdfbb26-207f-485e-afc1-80c8c4da7b07" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_ca5a59f5-785e-4535-a6f6-c974f9d3aa22" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afdfbb26-207f-485e-afc1-80c8c4da7b07" xlink:to="loc_dei_DocumentInformationTable_ca5a59f5-785e-4535-a6f6-c974f9d3aa22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b108e940-5d03-4346-8063-e4a2adda666c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_ca5a59f5-785e-4535-a6f6-c974f9d3aa22" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b108e940-5d03-4346-8063-e4a2adda666c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b108e940-5d03-4346-8063-e4a2adda666c" xlink:to="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_66c46225-a9f2-4f29-bb67-204d1b6aa095" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:to="loc_us-gaap_CommonStockMember_66c46225-a9f2-4f29-bb67-204d1b6aa095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_6750377f-0849-48fb-a856-9bde4217fb78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_688c03a2-b42f-4e3b-87e2-6b5231ae7ba7" xlink:to="loc_us-gaap_PreferredStockMember_6750377f-0849-48fb-a856-9bde4217fb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_ca5a59f5-785e-4535-a6f6-c974f9d3aa22" xlink:to="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e213e1f4-3095-4605-a799-d4a99a84f61d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_DocumentType_e213e1f4-3095-4605-a799-d4a99a84f61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_acab0ebe-8277-4d76-848d-114035d98e63" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_DocumentPeriodEndDate_acab0ebe-8277-4d76-848d-114035d98e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fc3a29b6-9331-4278-ba6b-f657baa3837d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityRegistrantName_fc3a29b6-9331-4278-ba6b-f657baa3837d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4a0c4664-37a0-40e7-9897-253d557d1dcc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4a0c4664-37a0-40e7-9897-253d557d1dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3bd588a1-02b0-4e6f-86cd-7e041326c37b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityFileNumber_3bd588a1-02b0-4e6f-86cd-7e041326c37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_673350d4-a58b-45cb-990d-9e85ca6a25ff" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityTaxIdentificationNumber_673350d4-a58b-45cb-990d-9e85ca6a25ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_102b5612-45f8-4e09-8c28-fe7f735c57d2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressAddressLine1_102b5612-45f8-4e09-8c28-fe7f735c57d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5ba26a69-5f5a-4776-b696-da5988fab302" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressCityOrTown_5ba26a69-5f5a-4776-b696-da5988fab302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4d7b2a98-8a49-4607-be45-f6bd46145a11" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressStateOrProvince_4d7b2a98-8a49-4607-be45-f6bd46145a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a55ed4e9-bcfc-40a3-bdcb-fb9a380b57c6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityAddressPostalZipCode_a55ed4e9-bcfc-40a3-bdcb-fb9a380b57c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_abef4ded-6e72-4efa-ab66-45d65b79312d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_CityAreaCode_abef4ded-6e72-4efa-ab66-45d65b79312d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1e13a244-e325-4331-a06e-07d3c021a243" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_LocalPhoneNumber_1e13a244-e325-4331-a06e-07d3c021a243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_7ce1b514-cc95-4e75-be6a-315e9ad1c2b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_WrittenCommunications_7ce1b514-cc95-4e75-be6a-315e9ad1c2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_696d72e2-82a8-46a7-a5a0-01dc9fdc5663" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_SolicitingMaterial_696d72e2-82a8-46a7-a5a0-01dc9fdc5663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_b08fdf78-0531-4b5c-b664-d24b1775b6a1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_PreCommencementTenderOffer_b08fdf78-0531-4b5c-b664-d24b1775b6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6cd82c31-38be-46ff-ab41-4d03d83b4848" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6cd82c31-38be-46ff-ab41-4d03d83b4848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_262f4ae7-3b86-4d9b-aa8e-6620b350db2c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_Security12bTitle_262f4ae7-3b86-4d9b-aa8e-6620b350db2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9936a717-3e74-4974-9ba4-660abfbcdc48" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_TradingSymbol_9936a717-3e74-4974-9ba4-660abfbcdc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dbc6c04e-3b05-4555-b727-025d780c8eaf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_SecurityExchangeName_dbc6c04e-3b05-4555-b727-025d780c8eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_dd760837-dc71-4b23-bea9-de655eb93dfc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_NoTradingSymbolFlag_dd760837-dc71-4b23-bea9-de655eb93dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7bf936e8-36c3-4e14-a164-c0ca0402f156" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityEmergingGrowthCompany_7bf936e8-36c3-4e14-a164-c0ca0402f156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_39725ebb-7108-4b11-a6b4-991898999b01" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_EntityCentralIndexKey_39725ebb-7108-4b11-a6b4-991898999b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_eef70f82-f3fb-4099-a1fc-d0833cb0162b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_fd91e43b-54a5-418d-a4f8-760525df6ff1" xlink:to="loc_dei_AmendmentFlag_eef70f82-f3fb-4099-a1fc-d0833cb0162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 19,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PetMed Express, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Stock Purchase Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pets-20251019.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="pets-20251019.htm">pets-20251019.htm</File>
    <File>pets-20251019.xsd</File>
    <File>pets-20251019_def.xml</File>
    <File>pets-20251019_lab.xml</File>
    <File>pets-20251019_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "pets-20251019.htm": {
   "nsprefix": "pets",
   "nsuri": "http://www.1800petmeds.com/20251019",
   "dts": {
    "inline": {
     "local": [
      "pets-20251019.htm"
     ]
    },
    "schema": {
     "local": [
      "pets-20251019.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "pets-20251019_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20251019_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20251019_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 25
   },
   "report": {
    "R1": {
     "role": "http://www.1800petmeds.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20251019.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20251019.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No Trading Symbol Flag",
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock [Member]",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001040130-25-000077-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001040130-25-000077-xbrl.zip
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M2A61#C0'(@EC.1\(OZJE,2F*L5[,(BEN<)Q"/;?!VX&E<9\^K&(:L?\8^O/
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M0MAXC%P/S?ALQGRLOPSF-B&GTLX&NN5!0*8B\(U_G*E$@KY"H ?3URC2,$S
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M6":^2]'BP?(_42"LJYDP KZ:N]SRGQA7_5-\_==$@;8V4N$Y"9)G(@'G2VN
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MEN)C>^SO9?VHB*U!/YVKUR-!C(^$7XL2WI\/>8$(25GK&:$\H!;0F5@=$S%
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MB-;K?4+8C>BE>?3JV?:98OWOM5X]^S]02P,$%     @ RH)56[>[4DPO"
M14$  !4   !P971S+3(P,C4Q,#$Y7W!R92YX;6S5FUEOVT@2Q]_S*;2>UVVK
M[R-(,O ZR<*8'$;BP0SV1>BCVB8BD09)Q_:WWR)M)7%\C$;D0-*+#JK)JOKW
M3]W5U>2+7Z\6\\E7J)NB*E_NL7VZ-X$R5JDH3U_N_7[REMB]7U\]>_;B7X3\
M^9]/[R:OJWBQ@+*='-;@6TB3RZ(]F[1G,/FCJK\47_WD>.[;7-4+0E[UIQU6
MY]=U<7K63CCE:MEL^6O]/'"5C-:1B)"!2.J ! V:>".UT=E0+_B_3Y^#,@R
M<R*\541ZEXCW7)'$K3*05.3.]1>=%^67Y]U+\ U,,+RRZ;^^W#MKV_/GT^GE
MY>7^5:CG^U5].N64BNFR]=YM\ZM[[2]%WYHYYZ;]K]^:-L5##?&R;/KG^W>?
MXQDL/"G*IO5E[ PTQ?.F/_BNBK[M5?]+OR:/MNB^D64STATB#"5B^U=-VGOU
M;#*YD:.NYO )\J1[__W3T1V3S%)Z#NT"4K,?J\6T:S,]K) )]+8_N[T^AY=[
M3;$XG\/RV%D-^>4>GM>0KEL99:ZS^<O-B=/OIL]K:)"7/M1W>.#V_,[*6F[
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M69 JEIHYD*>3!B]N!*\-U,[I#":'WO")#ZM"!,*D0W:X:Z[18$)L;BQ:+,$
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M-=[%=/KK\$><7_,?C_X'4$L#!!0    ( ,J"55MFWM;EWC<  *M! 0 >
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MLN513J0JCU?8CIMY&L^#J%0!:@6HP,4?\^(&=(*92OCN9516J=+8CTKEI%K
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M7K?0%M$*KHATD<.Y;AJ.S<:G3$%-""J8(5J<]/]Y5'%OBP5L(EV7:/??I*!
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M$/R*)_GG^_:_YF!_AF^_N>%-/1/V]X<M(=J-<3LG^%JO-YYV7GU!(;4&L^O
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MY?Q7.ZN//^^L_N>D2%;POWFUR'[Z7U!+ 0(4 Q0    ( ,J"55N'=SEQIA@
M *^2   1              "  0    !P971S+3(P,C4Q,#$Y+FAT;5!+ 0(4
M Q0    ( ,J"55MVI!RSB (  (((   1              "  =48  !P971S
M+3(P,C4Q,#$Y+GAS9%!+ 0(4 Q0    ( ,J"55L0X.'V>P@  &,^   5
M          "  8P;  !P971S+3(P,C4Q,#$Y7V1E9BYX;6Q02P$"% ,4
M" #*@E5;U#0VG8@,   N;0  %0              @ $Z)   <&5T<RTR,#(U
M,3 Q.5]L86(N>&UL4$L! A0#%     @ RH)56[>[4DPO"   14$  !4
M         ( !]3   '!E=',M,C R-3$P,3E?<')E+GAM;%!+ 0(4 Q0    (
M ,J"55M ?J,Z7A$  $,Z   >              "  5<Y  !P971S+6IA;65S
M;&%C86UP<')E<W-R96QE82YH=&U02P$"% ,4    " #*@E5;9M[6Y=XW  "K
M00$ '@              @ 'Q2@  <&5T<RUX8V%M<&)E;&QE;7!L;WEM96YT
<86<N:'1M4$L%!@     '  < WP$   N#      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>pets-20251019_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pets-20251019.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2025-10-19</startDate>
            <endDate>2025-10-19</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-19</startDate>
            <endDate>2025-10-19</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-19</startDate>
            <endDate>2025-10-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0001040130</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-10-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">PetMed Express, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-28827</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">526-4444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-17">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-18">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-20">Preferred Stock Purchase Rights</dei:Security12bTitle>
    <dei:NoTradingSymbolFlag contextRef="c-3" id="f-21">true</dei:NoTradingSymbolFlag>
    <dei:SecurityExchangeName contextRef="c-3" id="f-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
